Virgin Herbert 4
4 · Vir Biotechnology, Inc. · Filed Mar 11, 2022
Insider Transaction Report
Form 4
Virgin Herbert
EVP, Research & CSO
Transactions
- Exercise/Conversion
Common Stock
2022-03-10$1.53/sh+9,000$13,770→ 184,407 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-03-10−9,000→ 210,505 totalExercise: $1.53Exp: 2028-01-26→ Common Stock (9,000 underlying)
Footnotes (1)
- [F1]The option is fully vested and exercisable.